5 March 2019
Health for Life Capital II™, World Leading Microbiome-focused Fund Announces its First Close
Health for Life Capital II™ to focus on the microbiome, and health, nutrition and digital/connected health sectors.
Life Sciences
21 February 2019
BiomX raises $32M series B to bring first two therapies to clinic
Phage therapy company BiomX Ltd. (Ness Ziona, Israel) raised a $32 million series B round on Wednesday, 20th February, that will take its lead candidate, acne therapy BX001,...
20 February 2019
Seventure Keeps up Pace of Its International Microbiome Investments, Closing Four Deals Spanning Seed to Series C
Seventure Keeps up Pace of Its International Microbiome Investments, Closing Four Deals Spanning Seed to Series C
19 February 2019
Vedanta Biosciences Publishes Seminal Research in Leading Scientific Journal for its Immuno-oncology Candidate, VE800
Vedanta Bioscience, a clinical-stage company developing a new category of therapies for immune-mediated diseases based on rationally-defined consortia of human...
19 February 2019
MycoTechnology, a FoodTech company, has raised $30 million in a Series C funding round
The latest investment will help drive expansion and accelerate research & development to introduce new and novel ingredients to the market.
30 January 2019
MycoTechnology Raises $30 Million in Series C Financing Round with Investments from the Biggest Names in Food
The $30 million in new investment will fuel expansion and accelerate R&D project execution. This funding round opens up an opportunity to explore different ways to meet...
18 January 2019
Cees de Jong: new Chairman of the joint start-up A-Mansia Biotech
A-Mansia Biotech, a microbiome company, has announced the appointment of Cees de Jong as the Chairman of its Board of Directors. His experience of successfully managing several...
13 December 2018
Israeli microbiome co BiomX teams with Johnson & Johnson
Israeli microbiome company BiomX, which is developing customized phage therapies, has announced that it has entered into a collaboration with Janssen the therapy R&D arm of...
5 November 2018
Next decade set to herald industry confidence in microbiome-based therapies, says new report
Taking on board learnings from challenges already faced and focusing on advanced, longer-term studies of variables within microbiome research will be key to fostering...
25 October 2018
Microbiotica Attracts Equity Investment from Seventure’s Health for Life Capital™ Fund
The company, which was founded in 2016 to develop transformational technology developed at the Sanger Institute, has made rapid progress in developing a unique capability to...